StartupsJul 15, 2026, 12:27 AM

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B

30-second summary

OpenAI researcher Miles Wang is reportedly raising funds for a new AI drug discovery startup valued at $2 billion, with Lightspeed leading the round.

TickrWire
OpenAI researcher Miles Wang in talks to launch AI drug discovery startup valued at $2B
Key takeaways
  • OpenAI researcher Miles Wang is launching a new startup.
  • The AI drug discovery firm seeks a $2 billion valuation.
  • Lightspeed is in discussions to lead the funding round.
  • Top AI talent continues to migrate into specialized biotech.
Full story

Miles Wang, a researcher at OpenAI, is negotiating a significant funding round for a new venture focused on artificial intelligence for drug discovery. The startup is targeting a valuation of $2 billion, highlighting the immense investor confidence in applying generative AI to biotechnology.

Lightspeed Venture Partners is reportedly in talks to lead the investment. This move signals a trend of top-tier talent leaving established AI labs to found specialized companies that leverage large models for scientific applications.

The proposed valuation is notable for a company at this stage, reflecting the high stakes and potential returns in the AI-driven pharmaceutical sector. Wang's background at OpenAI suggests the startup will likely utilize advanced machine learning techniques to accelerate the identification of new therapeutics.

Why this matters
Developers

Shows high demand for AI expertise in biotech applications.

Businesses

Signals massive capital flowing into AI pharma applications.

Investors

Highlights a potential unicorn in the making at a high entry valuation.

Sources · 1
Read next
More stories
TickrWireAI News Intelligence

We aggregate, verify, summarise and explain the latest artificial intelligence news from open, legal sources.

Daily AI digest

Top AI stories, summarised, in your inbox each morning.

© 2026 TickrWire. Summaries and analysis are AI-generated and may contain errors.